Scinai Immunotherapeutics Ltd. SCNI
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$0.52$0.57
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 460.00K | 269.00K | 269.00K | 269.00K | 187.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 460.00K | 269.00K | 269.00K | 269.00K | 187.00K |
| Cost of Revenue | 1.71M | 960.00K | 960.00K | 960.00K | 1.69M |
| Gross Profit | -1.25M | -691.00K | -691.00K | -691.00K | -1.50M |
| SG&A Expenses | 683.00K | 632.50K | 632.50K | 632.50K | 755.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.61M | 2.16M | 2.16M | 2.16M | 2.38M |
| Operating Income | -2.15M | -1.89M | -1.89M | -1.89M | -2.20M |
| Income Before Tax | -2.00M | -2.09M | -2.09M | -2.09M | -2.58M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.00M | -2.09M | -2.09M | -2.09M | -2.58M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.00M | -2.09M | -2.09M | -2.09M | -2.58M |
| EBIT | -2.15M | -1.89M | -1.89M | -1.89M | -2.20M |
| EBITDA | -1.56M | -1.53M | -1.53M | -1.53M | -1.84M |
| EPS Basic | -70.85K | -271.10K | -271.10K | -271.10K | -822.84K |
| Normalized Basic EPS | -1.24 | -4.24 | -4.24 | -4.24 | -12.86 |
| EPS Diluted | -70.85K | -271.10K | -271.10K | -271.10K | -822.84K |
| Normalized Diluted EPS | -1.24 | -4.24 | -4.24 | -4.24 | -12.86 |
| Average Basic Shares Outstanding | 1.13M | 307.90K | 307.90K | 307.90K | 125.30K |
| Average Diluted Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |